The place of antimicrobial chemotherapy in the treatment of adults with acute bronchitis: A double-blind placebo-controlled trial

Clinical Microbiology and Infection

Volumn 4, Issue 8, 1998, Pages 436-441

  Léophonte, Paul ^a   Murris Espin, Marlène ^a   Berthier, Alain ^b   Dayan, Maxime ^c  

^a CHU RANGUEIL   (France)

^b Cabinet de Pneumologie   (France)

^c Cabinet Medical   (France)

Author keywords

Acute bronchitis; Antibiotics; Healthy adult

Indexed keywords

ANTIBIOTIC AGENT; CEFUROXIME AXETIL;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SUPERINFECTION;

EID: 0031666061     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1998.tb00391.x     Document Type: Article

References (25)

1. Société de Pathologie Infectieuse de Langue Française. Les infections des voies respiratoires. Med Mal Infect 1991; 21(suppl): 1-8.
2. Verheij TJM, Hermans J, Mulder JD. Effects of doxycycline in patients with acute cough and purulent sputum: a double-blind placebo controlled trial. Br J Gen Pract 1994; 44: 400-4.
3. 10, 1991:8.
4. Carre P. Faut-il s'abstenir d'une antibiothérapie dans les infections bronchiques aiguës? Med Mal Infect 1992; 22(spécial): 153-9.
5. Gwaltney JM. Pleuropulmonary and bronchial infections: acute bronchitis. In Mandell GL, Douglas RG, Bennet JE, eds. Principles and practice of infectious diseases, 3rd edn. New York: Churchill Livingstone, 1990: 529-31.
6. Mouton Y, Bignolas G, Chidiac C, Decazes JM, Gehanno P, Groupe de Travail. Recommandations sur la prise en charge de la pathologie infectieuse respiratoire. Med Mal Infect 1995; 25(suppl): 1021-8.
7. Dunlay J, Reinhardt R, Donn Roi L. A placebo-controlled, double-blind trial of erythromycin in adults with acute bronchitis. J Fam Pract 1987; 25: 137-41.
8. Anthonisen NR, Manfred AJ, Warren CPW, Hershfield ES, Harding GKM, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204.
9. Tager J, Speizer FE. Role of infection in chronic bronchitis. N Engl J Med 1975; 292: 563-71.
10. Saint S, Bent S, Vittinghoff E, Grady D. Antibiotics in obstructive pulmonary disease exacerbations. A meta-analysis. JAMA 1995; 273. 957-60.
11. Francks P, Gleiner JA. The treatment of acute bronchitis with trimethoprim and sulfamethoxazole. J Fam Pract 1984; 19: 185-90
12. Brickfield FX, Carter WH, Johnson RE. Erythromycin in the treatment of acute bronchitis in a community practice. J Fam Pract 1986; 23: 1109-22.
13. Williamson HA. A randomized, controlled trial of doxycycline in the treatment of acute bronchitis. J Fam Pract 1984; 19: 481-6.
14. Stott NC, West RR. Randomized controlled trial of antibiotics in patients with cough and purulent sputum. Br Med J 1976; 2: 556-89.
15. McHoorney CA, Ware JE, Raczek AE The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247-63.
16. Perneger TV, Leplege A, Etter JF, Rangement A. Validation of French-language version of the MOSS 36-item short form health survey (SF-36) in young healthy adults. J Clin Epidemiol 1995; 48: 1051-60.
17. Davidson VE, Sanford BA. Factors influencing adherence of Staphylococcus aureus to influenza virus-infected cell cultures. Infect Immun 1982; 37: 946-55.
18. Sanford BA, Smith N, Shekolov A, Ramsay MA. Adherence of influenza A virus to group B streptococci. N Engl J Med 1967; 276: 604-8.
19. Winter J, Dhillon P. Penetration of cefuroxime into the bronchial mucosa following administration of cefuroxime axetil. J Antimicrob Chemother 1991; 27: 556-8.
20. Geslin P, Fremaux A, Sissia G. S. pneumoniae, infections respiratoires et sensibilité aux antibiotiques: place du céfuroxime axétil. Med Mal Infect 1991; 21(Hors série): 13-21.
21. Dabernat H, Delmas C, Lareng MB. Infections respiratoires à Haemophilus influenzae: intérêt du céfuroxime axétil. Med Mal Infect 1991; 21(Hors série): 22-6.
22. Reeves DS, Bywater MJ, Holt HA. The activity of cefpirome and ten other antibacterial agents against 2858 isolates collected from 20 centres. J Antimicrob Chemother 1993; 31: 345-62.
23. Dellamonica P Cefuroxime axetil. Int J Antimicrob Agents 1994; 4: 23-36.
24. Gonzales R, Sande M. What will it take to stop physicians from prescribing antibiotics in acute bronchitis? Lancet 1995; 345: 665-6.
25. Le Fur P, Sermet C. Broncho-pneumopathies aiguës et antibiothérapie en 1992. Aspects socio-économiques. Rapport du CREDES (Centre de Recherche d'Etude et de Documentation en Economie de la Santé), 1995; 1-19. Rapport No. 1062.